Carrier advocacy coverage letter for endovascular arteriovenous fistula (EndoAVF)
This product is provided in a downloadable PDF format.
The endovascular AVF evidence-based letter was written by IR physicians that are members of SIR's Carrier Advocacy Workgroup. The letter is intended to help IRs during the authorization, appeal or denial process with any payor denying this service.
Policy coverage topic: endovascular arteriovenous fistula (AVF) creation for the treatment of advanced chronic kidney disease (CKD) or end-stage renal disease (ESRD) anticipating or needing dialysis.
A subscription model applies to this product. The text, graphics and information are of a general nature; it is not a substitute for obtaining medical advice. We may update the documents at any time without prior notice.